Year: 2023

Image_20230327191436

L’Officiel Inc. SAS Granted Permits by the Ministry of Home Affairs of Malaysia to Publish Locally and Achieved Another Milestone Under the Direct Owner’s Model

NEW YORK & HONG KONG & SINGAPORE--(BUSINESS WIRE)--L’Officiel Inc. SAS (“L’Officiel”), a subsidiary of AMTD IDEA Group (NYSE: AMTD; SGX:...

LOGO-58

OliX Pharmaceuticals Doses First Patient in Clinical Trial for RNAi Therapeutic OLX10212 for Dry and Wet Age-related Macular Degeneration

SUWON, South Korea--(BUSINESS WIRE)--#AMD--OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the first patient...

LOGO-57

OliX Pharmaceuticals Doses First Patient in Clinical Trial for RNAi Therapeutic OLX10212 for Dry and Wet Age-related Macular Degeneration

SUWON, South Korea--(BUSINESS WIRE)--#AMD--OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the first patient...

logo-FN-purple-red

FiscalNote Announces Major New Customer Agreements with International Governments, Embassies, Agencies, Parliaments, and Ministries Across the Global Public Sector

Governments Increasingly Rely on FiscalNote’s Geopolitical, Policy, and Political Intelligence - Powered by AI - For Legislative Tracking, Issue Monitoring,...